Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits

Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that different at-home gut health tests—and even repeated tests from the same provider—can produce conflicting bacterial abundance estimates and divergent health categorizations. The findings highlight persistent gaps in standardization.

In work from the National Institute of Standards and Technology, (NIST; Gaithersburg, MD, USA) investigators evaluated commercially available, direct-to-consumer gut microbiome testing kits. These services analyze an individual’s fecal sample to profile microbiome composition and, in many cases, convert those data into health assessments. The team focused on analytical performance across brands and replicate submissions to understand how methodological differences affect reported results.

Image: The study\'s findings show persistent standardization gaps among at-home gut microbiome testing kits (Photo courtesy of Adobe Stock)

The study assessed 21 test kits from seven anonymized providers, all analyzing the same combined fecal sample from a single donor. Reported relative abundances of specific taxa varied widely between companies, with the genus Clostridium—encompassing pathogens such as Clostridioides difficile—among the most variable findings. For context, the American Gut Project’s average abundance for Clostridium was just over 2.5%, yet one company reported approximately five times that level, while three others failed to detect the genus in one or more submissions. Within-brand consistency also diverged: three identical samples sent to the same provider yielded conflicting health categorizations, with one labeled “unhealthy” and two labeled “healthy.”

The authors attribute the discrepancies to nonstandardized sampling procedures, sample processing and analysis pipelines, and the distinct metrics individual companies apply to generate health scores. They propose that standardizing sampling protocols and testing methods could improve the accuracy and interpretability of direct-to-consumer microbiome testing. The findings are published in Communications Biology on February 26, 2026.

Related Links
National Institute of Standards and Technology